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Despite numerous advances, treatment-resistant seizures remain an important problem.
Loss of neuronal inhibition is present in a variety of epilepsy models and is suggested as
a mechanism for increased excitability, leading to the proposal that grafting inhibitory
interneurons into seizure foci might relieve refractory seizures. Indeed, transplanted
medial ganglionic eminence interneuron progenitors (MGE-IPs) mature into GABAergic
interneurons that increase GABA release onto cortical pyramidal neurons, and this
inhibition is associated with reduced seizure activity. An obvious conclusion is that
inhibitory coupling between the new interneurons and pyramidal cells underlies this
effect. We hypothesized that the primary mechanism for the seizure-limiting effects
following MGE-IP transplantation is the tonic conductance that results from activation of
extrasynaptic GABAA receptors (GABAA-Rs) expressed on cortical pyramidal cells. Using
in vitro and in vivo recording techniques, we demonstrate that GABAA-R α4 subunit
deletion abolishes tonic currents (Itonic) in cortical pyramidal cells and leads to a failure of
MGE-IP transplantation to attenuate cortical seizure propagation. These observations
should influence how the field proceeds with respect to the further development of
therapeutic neuronal transplants (and possibly pharmacological treatments).
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Introduction
The treatment of seizures by transplantation of inhibitory interneurons into epileptic foci
is an area of considerable interest (Anderson and Baraban, 2012). Various transplantation
strategies have been employed to suppress epileptic activity (Raedt et al., 2007), including
the use of interneuron precursors harvested from the embryonic MGE (Alvarez-
Dolado et al., 2006; Baraban et al., 2009; Waldau et al., 2010; De la Cruz et al., 2011;
Henderson et al., 2014). Transplanted MGE-IPs differentiate into mature GABAergic
interneurons that provide inhibitory synaptic and extrasynaptic GABAergic transmission
onto cortical pyramidal neurons (Sultan et al., 2013). This inhibition is associated
with a reduction in seizure activity (Alvarez-Dolado et al., 2006; Baraban et al., 2009).
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Extrasynaptic activity, a response based on a distinct
population of GABAA receptors (GABAA-Rs), is of great
significance in mediating neuronal inhibition (Lee and Maguire,
2014). Immunohistochemical (Pirker et al., 2000; Chandra et al.,
2006; Hörtnagl et al., 2013) and pharmacologic (Brown et al.,
2002; Krook-Magnuson and Huntsman, 2005; Drasbek and
Jensen, 2006; Drasbek et al., 2007; Vardya et al., 2008) data
indicate that the GABAA-R α4 subunit contributes to the
formation of extrasynaptic GABAA-Rs in Layer 2/3 and Layer 4
cortical neurons in the rodent brain. In deeper neurons (Layer 5),
the α5 subunit contributes to the tonic current in both neonatal
(Sebe et al., 2010) and juvenile (Yamada et al., 2007) animals.
Importantly, a tonic current has also been observed in Layer
V-VI pyramidal cells from human neocortex, where less than
a third of the tonic current results from activation of GABAA-
Rs containing the α5 subunit (Scimemi et al., 2006), with the
subunit-basis of the remainder of the current unknown. It is
possible, however, that the non-α5 subunit-mediated current
is generated by GABAA-Rs containing the α4 subunit as α4
subunit mRNA is also present in those cells (Petri et al.,
2003).
GABA-mediated tonic inhibition appears to inhibit seizure
activity as the anticonvulsants vigabratin and tiagabine (which
inhibit GABA-transamninase and GABA reuptake, respectively)
increases the concentration of GABA in the brain (Petroff et al.,
1996; Richards and Bowery, 1996); importantly, this increase
results, in part, from non-vesicular release of GABA (Wu
et al., 2003). Deletion of the GABAA-R δ subunit, which co-
assembles with the α4 subunit (Sur et al., 1999; Jia et al., 2005)
and contributes to the formation of extrasynaptic GABAA-Rs
(Nusser et al., 1998; Sassoè-Pognetto et al., 2000; Brickley et al.,
2001; Nusser and Mody, 2002; Jia et al., 2005), is associated
with a decrease in α4 expression (Peng et al., 2002) and has
pro-convulsant effects (Spigelman et al., 2002). In dentate gyrus
cells in a rat TLE model, there was a significant decrease
in the neurosteroid-sensitive tonic current which occurred in
combination with a decrease in the surface expression of the
δ subunit (Peng et al., 2004; Rajasekaran et al., 2010), suggesting a
close relationship between extrasynaptic GABAA-Rs and seizure
activity. In a parallel fashion, there is a shift in α4 expression
from the extrasynaptic to synaptic membrane in the rat TLE
model (Sun et al., 2007), consistent with a loss of extrasynaptic
GABAA-Rs. In a rat traumatic brain injury model, there is a
significant decrease in the tonic current in semilunar granule
cells (SGCs; which are excitatory neurons located in the dentate
inner molecular layer), and the loss of the tonic current is
associated with a significant increase in input resistance and a
significant increase in SGC excitability (Gupta et al., 2012). In
the epileptic mutant mouse stargazer, there is a preferential loss
of extrasynaptic GABAA-Rs (Payne et al., 2006, 2007). More
compellingly, mutations associated with both febrile seizures and
childhood absence epilepsy compromise surface expression of
GABAA-Rs and reduce tonic GABA currents but do not affect
GABA-mediated synaptic events (Eugène et al., 2007). Finally, at
least one clinically relevant AED, gabapentin, has been shown to
enhance the tonic current in hippocampal neurons (Cheng et al.,
2006). Thus, activation of extrasynaptic GABAA-Rs represents a
novel approach to treating seizures arising in cortical, rather than
subcortical, structures (Cope et al., 2009).
Multiple animal models exist for studying seizure activity in
vivo (Pitkänen et al., 2006), including application of the transient
potassium current blocker, 4-aminopyridine (4-AP; Barna et al.,
2000; Bahar et al., 2006; Ma et al., 2009; Zhao et al., 2009, 2015;
Medina-Ceja and Ventura-Mejía, 2010; Salazar and Tapia, 2012;
Yu et al., 2014). We have chosen an acute, rather than chronic,
focal seizure mouse model for several reasons. First, a model
of partial onset epilepsy is required since MGE-IP transplants
are intended as a focal therapy. Second, the ictal events induced
with 4-AP last one to two minutes and appear electrographically
exactly like partial onset human epilepsy (Avoli, 1990; Perreault
and Avoli, 1991; Heinemann et al., 2006), beginning with low-
voltage, fast-activity and progressing to paroxysmal spike-and-
wave activity (Schwartz and Bonhoeffer, 2001). Third, ictogenesis
is reliable and easy to induce. Together, these attributes make
the 4-AP acute seizure model a viable and useful paradigm for
examining both underlying mechanism(s) as well as potential
treatment efficacy (Löscher, 2011).
We hypothesized that the observed seizure-limiting effect of
MGE-IP transplantation results from activation of extrasynaptic
GABAA-Rs expressed on cortical pyramidal cells. Determining
whether the reduction in ictal activity following MGE-IP
transplantation arises from synaptic or extrasynaptic activity
will guide the development of transplant-based therapies and
potential pharmacological treatments for medically refractory
seizure disorders.
Methods
All animal experiments were performed in accordance with
Institutional and Federal guidelines. The principles in
the ARRIVE Guidelines from The National Centre for the
Replacement, Refinement and Reduction of Animals in Research
(London, UK)1 were considered when planning the experiments.
To avoid periodic alterations in specific GABAAR subunits
during the estrous cycle in mice, which are associated with cyclic
changes of tonic inhibition and seizure susceptibility (Maguire
et al., 2005), only male mice were used for in vitro and in vivo
experiments.
In Vivo Transplantation of MGE Cells
Pan-green fluorescent protein (GFP)-expressing transgenic mice
were maintained on a CD1 background. At 13 days of gestation
(E13.5), dams were sacrificed, GFP+ embryos harvested, and
their brains removed. MGE-IP cells were obtained from 250 µm
sections by mechanical dissociation after separating the dorsal
and ventral MGE from adjacent brain regions (Figure 2A). Cells
were re-suspended in ice-cold neurobasal/B27 medium until
transplantation (De la Cruz et al., 2011).
Post-natal GABAA-R α4 subunit deletion (α4−/−) mice or
wild-type (α4+/+) male littermates at P30–40 were anesthetized
with sevoflurane and mounted in a stereotaxic frame. Using
a nanoinjector, 1.5 × 104 MGE-IP cells in 1.5–2.0 µl were
1http://www.nc3rs.org.uk/
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injected into the motor cortex (coordinates relative to Bregma:
anteroposterior (AP) −0.7 mm, mediolateral (ML) −1.0 mm,
and dorsoventral (DV) −1.0 mm) through a small burr hole. As
a sham control, in a separate group of animals, an equivalent
volume and number of MGE cells killed by freezing and thawing
was injected in the same location.
In Vitro Electrophysiology and Analysis
Whole-cell patch clamp recordings were made from visually
identified cortical layer 2/3 neurons in acutely prepared 300-µm
thick coronal brain slices (using IR/DIC microscopy) from
GABAA-R α4−/− mice and α4+/+ male littermates using a
Nikon Eclipse FN1 microscope equipped with a 4× objective
and a 40× water immersion objective and a high-sensitivity
monochrome digital camera (DS-Qi1, Nikon). Pyramidal cells
were selected based on pyramidal shape, apical dendrite,
and distance (200–300 µm) from pia. Standard whole-cell
patch clamp recordings were made in either the voltage or
current clamp configuration using a Multiclamp 700 amplifier
(Molecular Devices, Sunnyvale, CA) and pClamp 10.2 software
(Molecular Devices). Data were acquired at 10 kHz, filtered at
2.2 kHz, and digitized using a Digidata 1440A A/D interface
(Molecular Devices). All voltage clamp experiment recordings
were performed at −70 mV; neurons having resting membrane
potential greater than −45 mV were omitted from the study.
Liquid junction potential (+3.8 mV) was not corrected. Series
resistance was less than 25 MΩ following membrane rupture and
with whole-cell configuration established; data were excluded if
resistance changed by more than 20% over the course of the
recording. For analysis of sIPSC decay times, currents were fit
with a monoexponential function and the 80–20% decay time
recorded.
Drugs and Solutions
Salts and D-(-)-2-amino-5-phosphonopentanoic acid (AP5),
(±)-3-piperidine carboxylic acid (nipecotic acid; NPA) were
from Sigma-Aldrich (St. Louis, MO); bicuculline methochloride,
6-cyano-7-nitroquinoxaline-2, 3-dione (CNQX), 11, 12, 13,
13a-tetrahydro-7-methoxy-9-oxo-9H-imidazo [1, 5-a] pyrrolo
[2, 1-c] [1, 4] benzodiazepine-1-carboxylic acid, ethyl ester
(L655, 708), and (2S)-(+)-5, 5-dimethyl-2-morpholineacetic acid
(SCH 50911) were from Tocris (Bristol, UK). CNQX, AP5,
bicuculline, and NPA were dissolved in distilled water to a stock
concentration of 10, 20, 25 and 100 mM, respectively. L655, 708
and SCH 50911 were dissolved in dimethyl sulfoxide (DMSO)
to a stock concentration of 5 and 10 mM, respectively. Stock
solutions were kept at −20◦C and added to the extracellular
recording solution prior to recording.
The various solutions contained (in mM):
Slicing solution: 250 sucrose, 2 KCl, 5 MgCl2, 0.5 CaCl2,
1.25 NaH2PO4, 26 NaHCO3 and 10 D-glucose (ice-cold)
saturated with 95% O2/5% CO2.
Incubation extracellular solution: 126 NaCl, 3.6 KCl, 5 MgCl2,
0.5 CaCl2, 1.2 NaH2PO4, 26 NaHCO3 and 10 D-glucose; pH 7.4
when saturated with 95% O2/5% CO2. Incubation solution
was initially at 36◦C, and after 40 min the temperature of the
incubation solution was gradually lowered and slices were
maintained at room temperature (22–24◦C); all subsequent
electrophysiology experiments were performed at room
temperature.
Extracellular recording solution: 126 NaCl, 3.6 KCl,
1.5 MgCl2, 2.5 CaCl2, 1.2 NaH2PO4, 26 NaHCO3, 10 D-glucose
saturated with 95% O2/5% CO2. The extracellular recording
solution also contained: AP5 (20 µM), CNQX (10 µM), and
SCH 50911 (10 µM). When present, the final concentrations
of NPA, bicuculline, and L655, 708 were, respectively: 1 mM (a
concentration which completely blocks GABA reuptake (Keros
and Hablitz, 2005)), 50 µM, and 250 nM.
Intracellular solution: 135 KCl, 10 HEPES, 2 Mg-ATP,
0.2 Na-GTP, 0.5 EGTA; pH 7.4.
The magnitude of the tonic GABA-mediated current was
calculated by measuring the difference in the baseline whole-
cell current in the absence and presence of bicuculline (50 µM;
a concentration which is sufficient to block all GABAA-R-
mediated currents in brain slices (Yamada et al., 2007)). The
current clamp configuration was used to measure membrane
potentials. Tonic current amplitude was analyzed as a function
of genotype, and results were compared using either unpaired
Student’s t-test or the Mann-Whitney Rank Sum Test (if the
data did not pass either normality or equal variance tests)
as appropriate; p < 0.05 was considered significant. Data are
presented as mean± SEM.
In Vivo Electrophysiology
Methods employed here are similar to those previously reported
(De la Cruz et al., 2011). Briefly, thirty to forty days
post-transplantation, adult male mice were anesthetized with
isoflurane and mounted in a stereotaxic frame. Electrodes were
inserted into somatosensory cortex through a small cranial
window after opening the dura. A custom-designed chamber was
affixed to the skull and filled with silicone oil. Ictal discharges
were induced by injecting 4-AP (15 mM in 0.9% saline, 0.5
µl) through a single-barreled glass microelectrode placed 2 mm
away from the site of the transplant. The local field potential
(LFP) was recorded with two electrodes (see Figure 2E for
general configuration). Ictal onset was recorded from the same
electrode used for 4-AP injection (LFP1). Ictal propagation
was recorded from the site of transplantation (LFP2), which
was identified by the injection burr hole. A reference electrode
(secured by one miniature stainless steel screw) was placed into
the skull above the cerebellum. LFPs were amplified, filtered
(0.1–1,000 Hz) and digitized at 1 kHz using two AC/DC
differential amplifiers (Model 3000, A-M systems, Carlsborg,
WA). Data were recorded on a PC using a CED Power 1401 and
Spike2 software (Cambridge Electronic Design, Cambridge UK).
The amplitude and duration of ictal activity was recorded at each
of the two LFP electrodes, one in the 4-AP focus (LFP1) and the
other in the region of the cell transplants (LFP2) to determine
propagation efficacy.
4-AP in Vivo Data Analysis
Off-line analysis was performed using custom analysis software
written in Matlab (MathWorks, Natick, MA) (De la Cruz et al.,
2011). Seizure onset was determined by visual analysis of the
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LFP1 recording based on the morphology of the seizures.
In the 4-AP seizure model, most seizures start with a large
spike-and-wave, followed by a recruiting rhythm that evolves
into repetitive spike-and-wave discharges that dissipate with
progressive decrease in amplitude and increase in inter-spike
interval (Zhao et al., 2009). Consistent with our prior experience,
such activity persisted for up to 2 h (data not shown). This large
initial spike was used as the marker of ictal onset; termination
of ictal activity (offset) was determined by the cessation of the
spike-and-wave discharges and the return to baseline, pre-ictal
activity. The time windows between ictal onset and offset was
used for the further analysis. The average seizure duration at the
4-AP injection electrode (LFP1 recording site) was 33.6 ± 10.8 s
(315 seizures, 20 mice). After setting a threshold 2 × SD above
baseline activity, total LFP (ΣLFP) power was calculated as the
integral of the LFP power during each period of ictal activity (as
demarcated by ictal onset and offset as defined above). Baseline
activity was measured over a 2 s epoch prior to the initial ‘‘onset’’
spike.
The ratios of ΣLFP power and duration from LFP1
were compared to LFP2 to establish the effect of MGE
cells transplantation on each epileptic event. The power
and duration calculations were performed using custom-made
analysis program based on Matlab. The averaged ratio result
of all ictal discharges from an individual mouse was used
for the further group analysis. For fast Fourier transform
(FFT) analysis between LFP1 and LFP2, cross power spectrum
and coherence calculations were performed using ‘‘cpsd’’ and
‘‘mscohere’’ functions in Matlab (Bronzino, 1984; Davey et al.,
2000). Each computation used Welch’s averaged periodogram
method (Welch, 1967) with NFFT of 256 and a Hanning window
of the same size. Comparisons of the effects of transplantation
on the power ratio between the two groups, α4+/+ and α4−/−, as
a percentage of the power ratio for control killed cell injections
were performed with two-way ANOVA with Tukey-Kramer
post hoc analysis for multiple comparisons (SPSS Statistics,
IBM). Repeated-measures ANOVA was used for analysis of
both the cross spectral density estimates and magnitude-squared
coherence (MSC).
4-AP injected at site 1 (LFP1) simultaneously induces ictal
activity at both LFP1 and LFP2 recording sites under control
conditions (Figures 3A,C); this is in contrast to the situation
following MGE-IP transplantation in wild-type mice, where ictal
activity is significantly reduced at LFP2, but is preserved at the
LFP1 site of 4-AP injection (Figure 3B). Thus, ictal activity
induced by 4-AP injection reflects ictal propagation by cortical
spread rather than 4-AP diffusion.
Immunohistochemistry
Mice transplanted with MGE-IPs were intracardially perfused
with phosphate buffered saline (PBS) followed by 4%
paraformaldehyde prepared in PBS immediately after 4-AP
induced seizure experiments. Brains were stored in 4%
paraformaldehyde for at least 48 h to allow for proper fixation,
after which 50 µm-thick coronal sections were prepared. Free
floating sections were placed in blocking solution (5% bovine
serum albumin (BSA) in PBS with 3% triton) for 1 h followed
by incubation in primary antibody (chicken anti-GFP; 1:1000;
Abcam, Cambridge, MA) in blocking solution for 72 h at 4◦C.
Sections were then incubated in secondary antibody (Alexa-488
goat anti-chicken; 1:250; Life Technologies, Grand Island, NY)
for 2 h at room temperature, washed, mounted on a glass
slide with aqueous mounting medium (Fluoromount; Southern
Biotech, Birmingham, AL) and visualized using epifluorescent
microscopy.
Results
GABA activates synaptic GABAA-Rs, which underlie ‘‘phasic’’
inhibitory postsynaptic currents (IPSCs), as well as extrasynaptic
GABAA-Rs, which mediate persistent ‘‘tonic’’ currents (Lee and
Maguire, 2014). A limited repertoire of GABAA-Rs generate
Itonic, including those containing the α4 subunit (Lee and
Maguire, 2014). Evidence suggests that the GABAA-R α4 subunit
contributes to Itonic in cortical neurons (Chandra et al., 2006;
Drasbek et al., 2007). Electrophysiological confirmation of this
hypothesis is provided in Figure 1; the average tonic current
in α4+/+ pyramidal neurons was 9.0 ± 2.8 pA (n = 21).
Deletion of the α4 subunit abolishes Itonic (Figures 1A,B);
the average tonic current in α4−/− pyramidal neurons was
0.2 ± 1.0 pA (n = 11). Spontaneous IPSCs (sIPSCs) were
unaffected [average (from >2,000 events/genotype) amplitude,
decay time, and frequency for α4+/+ and α4−/− neurons
are, respectively: −48.2 ± 3.2 and −44.4 ± 2.6 pA, 11.5
± 0.6 and 10.2 ± 0.5 ms, and 4.2 ± 0.3 and 4.4 ± 0.3
Hz; Figure 1A inset]. Deletion of the α4 subunit results
in neuronal hyper-excitability (Figure 1C), consistent with a
lower threshold for chemically-induced seizures (Chandra et al.,
2008). Interestingly, however, the input resistance (Rin) was not
significantly different between the two genotypes (α4+/+, 125.8
± 11.9 M, n = 20 and α4−/−, 118.1 ± 6.1 M, n = 20;
p = 0.735, Mann-Whitney Rank Sum test as data did not
pass normality test). Preservation of Rin despite the loss of the
tonic GABAA-R α4 subunit-dependent Cl− conductance could
result from compensatory changes in a voltage-independent K+
conductance as is seen in response to loss of the tonic current
generated by GABAA-Rs containing the α6 subunit (Brickley
et al., 2001).
The GABAA-R α5 (but not α1) subunit has been proposed
to contribute to Itonic in cortical neurons (Drasbek et al.,
2007; Sebe et al., 2010; Lee and Maguire, 2014). This was
tested pharmacologically by increasing extracellular GABA
concentrations with nipecotic acid (NPA) in order to maximize
the detection of all possible GABAA-Rs to Itonic. Inhibition of
GABA reuptake with NPA significantly (Mann-Whitney Rank
Sum test) enhanced persistent currents in layer 2/3 pyramidal
cells from α4+/+ (147.3 ± 24.8 pA, n = 11) as compared
to α4−/− mice (66.7 ± 10.8 pA, n = 11; Figures 1D,E).
The NPA-induced ‘‘tonic’’ current in α4−/− neurons could
result from either α5 up-regulation and/or persistent activation
of low affinity synaptic GABAA-Rs. To evaluate the role of
the α5 subunit in generating this current, the GABAA-R α5
subunit-selective inverse agonist L655, 709 was co-applied with
NPA and found to have the same effect on Itonic in both
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FIGURE 1 | α4 subunit-containing GABAA-Rs are the basis of Itonic in
cortical pyramidal neurons. (A) Whole-cell currents from α4+/+ (top trace)
and α4−/− (bottom trace) layer II/III pyramidal cells in the absence and
presence of bicuculline (bic); traces truncated here and in d top for clarity.
sIPSCs are readily visible; inset shows overlay of averaged ensemble sIPSCs.
The solid line indicates average baseline current without bicuculline while the
dashed line indicates average baseline current in the presence of bicuculline.
All-points histograms (gray: control; black, bicuculline) highlight the shift in the
baseline current in the α4+/+, but not α4−/−, neuron. (A, right) (B) Bar graph
summarizing Itonic data. (C) Input-output curves for evoked spike firing in
neurons from α4+/+ and α4−/− mice. * p < 0.05 (Mann-Whitney Rank Sum
test). (D, left) Representative traces demonstrating that nipecotic acid (NPA)
enhances the persistent current in both α4+/+ (top trace) and α4−/− (bottom
trace) neurons. All-points histograms here (and in F) were constructed as in
Panel (A). (E) The effects of NPA are significantly different between genotypes
(Mann-Whitney Rank Sum Test). (F, left) Representative traces demonstrating
that superfusion of L655, 708 in the presence of NPA has a comparable effect
on persistent currents in α4+/+ (top trace) and α4−/− neurons (bottom
trace); this effect is not significant between genotypes (unpaired t-test) (G).
α4+/+ (26.8 ± 4.4 pA, n = 4) and α4−/− (25.1 ± 5.9
pA, n = 5) mice (Figures 1F,G), indicating that there is no
compensatory up-regulation of the α5 subunit in α4−/− mice.
The NPA-induced ‘‘tonic’’ current observed in α4−/− neurons
after α5 subunit blockade likely reflects persistent activation of
incompletely desensitized synaptic receptors (Keros and Hablitz,
2005).
We have previously demonstrated that transplantation of
medial ganglionic eminence interneuron precursors (MGE-
IPs) harvested from embryonic (E13.5) brain (Figure 2A) and
transplanted into the adult cortex results in long-term survival,
migration, and differentiation into interneurons (De la Cruz
et al., 2011). A population of transplanted MGE-IPs remains
at the site of injection (Figure 2B), and consistent with our
earlier reported results, MGE-IPs survive and migrate following
transplantation in α4+/+ (Figure 2C) and α4−/− (Figure 2D)
mice. In α4+/+ and α4−/− mice, the transplanted MGE-IPs
readily migrated throughout the cortex as far as 1 mm from
the injection site without apparent differences between the two
genotypes. These migratory cells display a pattern of arborization
consistent with mature neurons (Figures 2Cii,Dii).
As shown above (Figure 1C), deletion of the α4 subunit
results in neuronal hyper-excitability. Focal neocortical ictal
activity was evoked using 4-aminopyridine (4-AP) and measured
(Figures 2E, 3A–D) as described (De la Cruz et al., 2011).
Focal injection of 4-AP into somatosensory cortex 2 mm away
from the site of MGE-IP transplant (same site as LFP1 as
shown in Figure 2E) readily evoked ictal activity in α4+/+
(Figure 3A) and α4−/− (Figure 3C) mice under control (dead
cell) conditions. Ictal activity occurred simultaneously at
LFP1 and LFP2, indicating that 4-AP-induced ictal activity
resulted from electrical propagation by cortical spread rather
than 4-AP diffusion. 4-AP-induced seizure activity was not
significantly different between genotypes (Figure 3E). MGE-IP
transplantation significantly reduced seizure power in α4+/+
(F3,16 = 9.368, p < 0.01; Figures 3B,E), but not in α4−/−
animals (Figures 3D,E), while sham injections had no effect
(Figures 3A,C,E).
The raw LFP signal is a complex waveform which shows
temporal variations in multiple domains, including amplitude,
frequency, and phase. Fourier analysis isolates individual
components of a compound waveform, and has been used
to describe various aspects of the electrical seizure signal
(Bronzino, 1984; Hilfiker and Egli, 1992; Blanke et al., 2000;
Onoe and Nishigaki, 2004; Tsuchiya and Kogure, 2011). To
analyze ictal activity beyond the standard measures of duration
and total power, we also performed FFT analyses for cross
power spectrum and coherence, which are additional means
of analyzing the relationship between Fourier-transformed
domains of the underlying electrical waveform (Bronzino,
1984; Davey et al., 2000). FFT analysis showed that cross
spectral density estimate (F3,16 = 1.017, p > 0.05; Figure 3F)
and MSC (F3,16 = 76.116, p > 0.05; Figure 3G) of paired
LFP did not significantly differ between the four groups,
indicating that absence of the α4 subunit did not fundamentally
change seizure domain frequency. These data indicate that
the Itonic generated by GABAA-R α4 subunit expression is
required for the ictal power reduction following MGE-IP
transplantation.
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FIGURE 2 | Transplantation of green fluorescent protein (GFP)-positive
embryonic medial ganglionic eminence (MGE) cells into the adult cortex
results in long-term survival, migration, and arborization. (A) MGE
dissection in an E13.5 embryo. (B) Photomicrograph of a coronal brain section
from an α4+/+ mouse demonstrating residual clustering of MGE neurons 30
days post-transplantation at the site of injection (see Methods for stereotaxic
coordinates). Scale bar: 100 µm. (C,D) Low-power photomicrographs (scale
bar: 100 µm) of coronal brain sections from α4+/+ (Ci) and α4−/− (Di) mice
demonstrating that transplanted GFP+ neurons migrate from the site of injection
and form comparable arborization patterns. The transplanted MGE progenitors
migrated throughout the cortex, and as far as 1 mm from the injection site.
(Cii–Dii) Higher magnification images (scale bar: 50 µm) of the area indicated
by the white arrowhead in (Ci,Di) shows that the transplanted interneurons
have processes similar to mature neurons. (E) Image of the cortical surface
indicating the locations of the LFP1 electrode, the 4-AP injection site, the LFP2
electrode, and the MGE/control cell injection site.
Discussion
Synaptic receptors mediate phasic inhibition whereas
extrasynaptic receptors mediate tonic inhibition (Stell and
Mody, 2002; Mody and Pearce, 2004; Farrant and Nusser,
2005; Belelli et al., 2009). Identification of the GABAA-R α4
subunit as sufficient for the reduction in ictal activity following
MGE-IP transplantation suggests that extrasynaptic α4 subunit-
containing GABAA-Rs are important targets for treating seizures
arising in cortical, and perhaps subcortical, structures (Cope
et al., 2009). MGE-IP transplants were shown to increase both
phasic and tonic currents in cortical pyramidal neurons (Baraban
et al., 2009). Augmentation of tonic currents was reported to
be highly-efficient in enhancing inhibition (Bai et al., 2001).
Our data emphasize the importance of extrasynaptic GABAA-Rs
which contain the α4 subunit in constraining cellular and system
level excitability. Our findings are also consistent with the
observation that mutations associated with both febrile seizures
and childhood absence epilepsy compromise surface expression
of GABAA-Rs and reduce tonic GABA currents but do not affect
GABA-mediated synaptic events (Eugène et al., 2007).
Is it possible that other GABAA-R configurations might
contribute to the observed effect? δ subunit-containing GABAA-
Rs are exclusively extrasynaptic (Nusser et al., 1998; Wei et al.,
2003; Sun et al., 2004), and mediate tonic inhibition in dentate
gyrus granule cells (Nusser and Mody, 2002; Stell et al., 2003;
Wei et al., 2004; Maguire et al., 2005), cerebellar granule
cells (Watts and Thomson, 2005), thalamic neurons (Belelli
et al., 2005; Cope et al., 2005; Jia et al., 2005), and cortical
pyramidal neurons (Scimemi et al., 2006). α4 and δ subunits show
overlapping patterns of distribution (Peng et al., 2002), and the δ
subunit normally partners with either α4 or α6 subunits (Jones
et al., 1997; Sur et al., 1999; Jia et al., 2005), and while α1-δ
subunits co-assemble in heterologous expression systems (Feng
and Macdonald, 2004; Feng et al., 2004; Kaur et al., 2009; Baur
et al., 2010), the data for such expression in neurons, while extant,
is less extensive (Glykys et al., 2007).
Although the α1 subunit is well expressed in cortical neurons
(Fritschy and Möhler, 1995; Araujo et al., 1996; Dunning et al.,
1999; Pirker et al., 2000; Hörtnagl et al., 2013), it does not
appear to contribute to the formation of α1-δ extrasynaptic
GABAA-Rs in cortical neurons for the following reasons: (1) this
current is strongly enhanced by THIP (Drasbek and Jensen,
2006; Drasbek et al., 2007; Vardya et al., 2008), and we have
previously shown that α1-δ GABAA-Rs are relatively unaffected
by the low concentrations of THIP used in those experiments
(Jia et al., 2005), and more importantly; (2) there is no
detectable tonic current in cortical neurons from α4−/− mice
(Figure 1).
Of note, there is no evidence of compensatory up-regulation
in α5 or α1 subunit expression in α4−/− mice, and as might
be predicted, there is a significant concomitant decrease in
δ subunit expression (Suryanarayanan et al., 2011); the latter
effect is consistent with the decrease in δ subunit expression
that is seen in α6−/− mice (Jones et al., 1997), which is the
other major α subunit to contribute to extrasynaptic GABAA-Rs.
Together, those data emphasize the importance of α4 subunits
in the formation of extrasynaptic GABAA-Rs which also contain
the δ subunit. While the potential contribution of other subunits
might be worth pursuing using additional pharmacologic tools,
those results would not change the fundamental conclusion that
the α4 subunit contributes to the efficacy of MGE transplants in
constraining seizure power.
Consistent with in vivo data demonstrating an enhanced
sensitivity to the pro-convulsant pentylentetrazole (Chandra
et al., 2008), Layer 2/3 pyramidal cells from α4−/− were
hyperexcitable when compared to similar neurons from α4+/+
mice (Figure 1C). Surprisingly, Rin was unchanged despite the
loss the tonic current, although there is precedent for such
homeostatic compensation (Brickley et al., 2001). What then,
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FIGURE 3 | MGE-IP transplants fail to attenuate seizure propagation
in GABAA-R α4−/− mice. (A–D) local field potential (LFP) recording (left
panel) from an α4+/+ mouse under control conditions (A) and following
MGE-transplantation (B). (C,D) 4-AP-induced seizure-like electrical activity
recorded from α4−/− mice under control (C) and 30-days post-MGE
transplant (D) conditions. Right panel (A–D) displays the power spectral
density (PSD) of the LFP recording. (E) Summary data for ictal duration and
power for each condition by genotype. (F) Averaged cross spectral density
estimate and (G) averaged magnitude-squared coherence (MSC) for each
condition by genotype.
could account for the change in excitability? Action potentials
primarily arise in the axon initial segment (AIS; Bender and
Trussell, 2012). GABAA-Rs have been shown to cluster at the
AIS (Christie and De Blas, 2003; Muir and Kittler, 2014), even
in the absence of GABAergic innervation (Christie and De Blas,
2003). Recently, it has been shown that inhibitory input to the
AIS constrains both action potential formation and epileptiform
activity in vitro, even more robustly than perisomatic inhibition
(Wang et al., 2014). Thus, if extrasynaptic GABAA-Rs are lost
at the AIS while there is a concomitant increase in an outward
somatic K+ conductance, there will be an increase in excitability
even though the overall input resistance of the cell would be
unchanged. Future additional experiments will be required to test
this hypothesis.
There are limitations to the present study. The implicit
assumption is that efficacy of MGE transplantation in reducing
ictal activity arises from an increase in GABAergic inhibition;
such inhibition can be phasic, tonic (or both). Indeed, MGE
transplantation has been shown to increase both phasic and
tonic inhibition onto host cortical pyramidal cells, but not
host interneurons, in Kv1.1 null mice (Baraban et al., 2009).
Whether such an increase occurs following MGE transplantation
in our animal model remains to be determined. Similarly, it
is possible than the enhancement of phasic currents might
also be sufficient for the observed efficacy. The α1 subunit
contributes to GABAA-Rs at cortical pyramidal neuron synapses
in adult animals (Bosman et al., 2005), and as α1 gene deletion
mice have been generated (Sur et al., 2001; Vicini et al., 2001)
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this hypothesis could be tested; however, phasic activity is
well preserved in multiple brain regions, including the cortex,
despite the loss of the α1 subunit (Vicini et al., 2001; Goldstein
et al., 2002; Bosman et al., 2005). This suggests that there is a
strong compensatory mechanism to preserve synaptically driven
GABAergic inhibition, and so multiple mouse models would
appear to be required to adequately test the role of MGE-
mediated enhanced phasic inhibition. Finally, differences in cell
survival and/or patterns of arborization might also account for
the observed lack of transplant efficacy in α4−/− mice, but
the degree to which survival and arborization appear to be
comparable (Figures 2C,D) suggests that this is not the case.
Our results are consistent with the recently reported observation
that expression of the GABAB1 receptor subunit is not required
for the migration and laminar distribution of MGE-IPs in the
neocortex following transplantation (Sebe et al., 2014).
Interestingly, merely increasing overall GABA concentration,
and activating all GABAA-Rs as with vigabatrin or tiagabine,
to treat acquired seizures is not sufficient given the relatively
poor side-effect profile associated with this approach. Our data
confirm that activation of extrasynaptic, rather than synaptic,
GABAA-Rs is the basis for the reduction in seizure activity
following MGE transplants, and should allow us to refine the
overall approach and facilitate the translation of a promising
experimental observation into a clinically valuable therapy that
can be used to treat patients. Cortical interneurons, including
those originating in the MGE, are heterogeneous, and are
classified by their morphology, neurochemical content, and
electrophysiological properties (Sultan et al., 2013). Selection
of an interneuron population that preferentially enhances
extrasynaptic GABAA-R activity may improve the efficacy
of cell-based therapies for the treatment of seizures arising
in the cortex. Neurogliaform-type cells provide inhibitory
input to cortical neurons (Tamás et al., 2003; Miyoshi
et al., 2010) in a non-synaptic, spatially non-specific manner
that can activate extrasynaptic GABAA-Rs (Oláh et al.,
2009). Whether transplantation of neurogliaform interneurons
can reduce seizure activity more effectively than a mixed
population of interneurons remains to be tested once methods
to obtain a pure population of neurogliaform progenitors
is developed. Lastly, our data reveal a potentially novel
target for drug development, which could be exploited as
an alternative and/or complimentary approach to cell-based
therapies.
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